StonvexLoading…
StonvexStonvexStonvexCore line items from ENTG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $3.20B | $3.24B | $3.52B | $888.24M |
Operating Income | $455.90M | $533.90M | $499.20M | Not available |
Net Income | $235.60M | $292.80M | $180.70M | $33.21M |
EPS (Diluted) | $1.55 | $1.93 | $1.20 | $0.22 |
Total Assets | $8.35B | $8.39B | $8.81B | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $360.40M | $329.20M | $456.93M | Not available |
Free Cash Flow OCF − CapEx | $396.20M | $316.10M | $187.70M | Not available |
Shares Outstanding | 151.90M | 151.10M | 150.36M | Not available |